Alpha DNA Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-439
| Closed | -$313K | – | 142 |
|
|
2024
Q4 | $313K | Sell |
439
-191
| -30% | -$136K | 0.12% | 182 |
|
|
2024
Q3 | $662K | Buy |
630
+281
| +81% | +$295K | 0.25% | 91 |
|
|
2024
Q2 | $367K | Sell |
349
-257
| -42% | -$270K | 0.14% | 176 |
|
|
2024
Q1 | $583K | Sell |
606
-735
| -55% | -$707K | 0.22% | 107 |
|
|
2023
Q4 | $1.18M | Buy |
1,341
+712
| +113% | +$625K | 0.46% | 38 |
|
|
2023
Q3 | $518K | Buy |
+629
| New | +$518K | 0.21% | 132 |
|
|
2021
Q2 | – | Sell |
-34
| Closed | -$16K | – | 524 |
|
|
2021
Q1 | $16K | Buy |
34
+3
| +10% | +$1.41K | 0.02% | 265 |
|
|
2020
Q4 | $14K | Buy |
+31
| New | +$14K | 0.01% | 281 |
|